House Roll Call 317, 117th Congress · October 19, 2021

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act

Question before the chamber: On Motion to Suspend the Rules and Pass, as Amended

368 yea · 56 nayPassed7 not voting or present

Democrat217 yea · 0 nay

Republican151 yea · 56 nay

Solid = yea, faded = nay.

The measure

H.R. 4369 ↗

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

Health CareDirection unreadable — not scored
excluded:model-unclear (0.85) Focuses on drug manufacturing technology and grants, not health insurance coverage.
Tagged by: policy-area:Health
Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (368)

Nay (56)

Not voting or present (7)

Stephanie I. BiceDid not vote
Kevin BradyDid not vote
Emanuel CleaverDid not vote
Tom ColeDid not vote
Doug LaMalfaDid not vote
Gary J. PalmerDid not vote
Maxine WatersDid not vote

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.